Sales rise 49.36% to Rs 722.12 crore
Net profit of ERIS Lifesciences declined 18.60% to Rs 83.63 crore in the quarter ended December 2024 as against Rs 102.74 crore during the previous quarter ended December 2023. Sales rose 49.36% to Rs 722.12 crore in the quarter ended December 2024 as against Rs 483.48 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var.Sales722.12483.48 49 OPM %34.6636.30 -PBDT197.36161.59 22 PBT116.16115.87 0 NP83.63102.74 -19Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
